it has been in a long downtrend and its valuation is sky-high. breaking under $1 is a poor sign short term. i think it is looking to be a long process. they have been over this ground before and nothing ever materialized that was sustainable. people and businesses do not like change and the stakes are really high. if a company switches and then someone gets sick, there will be a monster lawsuit. monster. no one wants to be the first company to take the bullet from that suit. after 5 successful lawsuits or an FDA directive mandating change, then companies will change. that is why there is no apparent talk of a qsr using sdc as primary or sole agent. sure they may "use" it as a secondary step, but where is the commitment to actually change protocols? the value of the company might be a few million dollars; who knows. 30 million? with no revenue after years of effort? tough to maintain.